Originally Posted by
Roger Ramjets
...
These drugs are expensive so there might be a tendency to only use them on 'deserving' cases like Giuliani, while others not considered 'valuable' enough miss out. If the drugs don't work it doesn't matter, but if they do then it could be a moral dilemma. I would hate to think that Giuliani got preferential treatment that resulted in another person dying.
It's not the cost that is the only barrier, it's that the drugs are new and don't have full FDA approval.
However, 3rd party payers won't reimburse for these drugs. So if that is not an issue because one is rich, it obviously improves one's chances of getting the drugs.